Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-17CBUS3SEC Filing Summary
This filing details a change in beneficial ownership for Thomas Urban, a director at Cibus, Inc. The report indicates that following a transaction, Thomas Urban directly owns 0 shares of Class A Common Stock. The filing date was April 17, 2026, with the reportable period ending April 7, 2026. The filing is Form 3, whic...
Micro CapBiotechnology
2026-04-17GHRS3Duncan Moore's Form 3 Filing for GH Research PLC Director Share Ownership
This Form 3 filing discloses the initial beneficial ownership of GH Research PLC securities by Duncan Moore, a director of the company. The filing reports Moore's ownership of 14,600 ordinary shares and five separate share option grants totaling 72,340 options with an exercise price of $0.025 per share. The options hav...
Small CapBiotechnology
2026-04-17ALXO3Power of Attorney for Knight Jeff E.
Knight Jeff E., Chief Dev & Operating Officer of ALX Oncology Holdings Inc., has executed a Power of Attorney document. This document appoints Jason Lettmann, Harish Shantharam, and Shelly Wong as attorneys-in-fact. They are authorized to complete and execute SEC filings, including Forms 3, 4, and 5, and any amendments...
Micro CapBiotechnology